These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 35181787)

  • 1. Inhibiting Type I Arginine Methyltransferase Activity Promotes T Cell-Mediated Antitumor Immune Responses.
    Fedoriw A; Shi L; O'Brien S; Smitheman KN; Wang Y; Hou J; Sherk C; Rajapurkar S; Laraio J; Williams LJ; Xu C; Han G; Feng Q; Bedford MT; Wang L; Barbash O; Kruger RG; Hwu P; Mohammad HP; Peng W
    Cancer Immunol Res; 2022 Apr; 10(4):420-436. PubMed ID: 35181787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer.
    Zhang S; Guo L; Zhang Z; Liu X; Chen W; Wei Y; Wang X; Wu Q
    Cancer; 2024 Apr; 130(S8):1415-1423. PubMed ID: 38079306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein arginine methyltransferases (PRMTs): Orchestrators of cancer pathogenesis, immunotherapy dynamics, and drug resistance.
    Gao Y; Feng C; Ma J; Yan Q
    Biochem Pharmacol; 2024 Mar; 221():116048. PubMed ID: 38346542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patent review of arginine methyltransferase inhibitors (2010-2018).
    Li X; Wang C; Jiang H; Luo C
    Expert Opin Ther Pat; 2019 Feb; 29(2):97-114. PubMed ID: 30640571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and II PRMTs inversely regulate post-transcriptional intron detention through Sm and CHTOP methylation.
    Maron MI; Casill AD; Gupta V; Roth JS; Sidoli S; Query CC; Gamble MJ; Shechter D
    Elife; 2022 Jan; 11():. PubMed ID: 34984976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising role of protein arginine methyltransferases in overcoming anti-cancer drug resistance.
    Zhu Y; Xia T; Chen DQ; Xiong X; Shi L; Zuo Y; Xiao H; Liu L
    Drug Resist Updat; 2024 Jan; 72():101016. PubMed ID: 37980859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining protein arginine methyltransferase inhibitor and anti-programmed death-ligand-1 inhibits pancreatic cancer progression.
    Zheng NN; Zhou M; Sun F; Huai MX; Zhang Y; Qu CY; Shen F; Xu LM
    World J Gastroenterol; 2020 Jul; 26(26):3737-3749. PubMed ID: 32774054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor Activity of the Type I PRMT Inhibitor, GSK3368715, Synergizes with PRMT5 Inhibition through MTAP Loss.
    Fedoriw A; Rajapurkar SR; O'Brien S; Gerhart SV; Mitchell LH; Adams ND; Rioux N; Lingaraj T; Ribich SA; Pappalardi MB; Shah N; Laraio J; Liu Y; Butticello M; Carpenter CL; Creasy C; Korenchuk S; McCabe MT; McHugh CF; Nagarajan R; Wagner C; Zappacosta F; Annan R; Concha NO; Thomas RA; Hart TK; Smith JJ; Copeland RA; Moyer MP; Campbell J; Stickland K; Mills J; Jacques-O'Hagan S; Allain C; Johnston D; Raimondi A; Porter Scott M; Waters N; Swinger K; Boriack-Sjodin A; Riera T; Shapiro G; Chesworth R; Prinjha RK; Kruger RG; Barbash O; Mohammad HP
    Cancer Cell; 2019 Jul; 36(1):100-114.e25. PubMed ID: 31257072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C. elegans PRMT-3 possesses a type III protein arginine methyltransferase activity.
    Takahashi Y; Daitoku H; Yokoyama A; Nakayama K; Kim JD; Fukamizu A
    J Recept Signal Transduct Res; 2011 Apr; 31(2):168-72. PubMed ID: 21385054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition.
    Li Y; Dobrolecki LE; Sallas C; Zhang X; Kerr TD; Bisht D; Wang Y; Awasthi S; Kaundal B; Wu S; Peng W; Mendillo ML; Lu Y; Jeter CR; Peng G; Liu J; Westin SN; Sood AK; Lewis MT; Das J; Yi SS; Bedford MT; McGrail DJ; Sahni N
    Cell Rep Med; 2023 Dec; 4(12):101326. PubMed ID: 38118413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hnRNP-A1 as a pharmacodynamic biomarker of type I PRMT inhibition in blood and tumor tissues.
    Noto PB; Sikorski TW; Zappacosta F; Wagner CD; Montes de Oca R; Szapacs ME; Annan RS; Liu Y; McHugh CF; Mohammad HP; Piccoli SP; Creasy CL
    Sci Rep; 2020 Dec; 10(1):22155. PubMed ID: 33335114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.
    Eram MS; Shen Y; Szewczyk M; Wu H; Senisterra G; Li F; Butler KV; Kaniskan HÜ; Speed BA; Dela Seña C; Dong A; Zeng H; Schapira M; Brown PJ; Arrowsmith CH; Barsyte-Lovejoy D; Liu J; Vedadi M; Jin J
    ACS Chem Biol; 2016 Mar; 11(3):772-781. PubMed ID: 26598975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macromolecular complexes of histones affect protein arginine methyltransferase activities.
    Fulton MD; Cao M; Ho MC; Zhao X; Zheng YG
    J Biol Chem; 2021 Oct; 297(4):101123. PubMed ID: 34492270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the PRMT gene family in rice reveals conservation of arginine methylation.
    Ahmad A; Dong Y; Cao X
    PLoS One; 2011; 6(8):e22664. PubMed ID: 21853042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique Features of Human Protein Arginine Methyltransferase 9 (PRMT9) and Its Substrate RNA Splicing Factor SF3B2.
    Hadjikyriacou A; Yang Y; Espejo A; Bedford MT; Clarke SG
    J Biol Chem; 2015 Jul; 290(27):16723-43. PubMed ID: 25979344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein Arginine Methylation: An Emerging Modification in Cancer Immunity and Immunotherapy.
    Dai W; Zhang J; Li S; He F; Liu Q; Gong J; Yang Z; Gong Y; Tang F; Wang Z; Xie C
    Front Immunol; 2022; 13():865964. PubMed ID: 35493527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous ablation of prmt-1 and prmt-5 abolishes asymmetric and symmetric arginine dimethylations in Caenorhabditis elegans.
    Hirota K; Shigekawa C; Araoi S; Sha L; Inagawa T; Kanou A; Kako K; Daitoku H; Fukamizu A
    J Biochem; 2017 Jun; 161(6):521-527. PubMed ID: 28158808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo analysis of the major type I protein arginine methyltransferase from Trypanosoma brucei.
    Pelletier M; Pasternack DA; Read LK
    Mol Biochem Parasitol; 2005 Dec; 144(2):206-17. PubMed ID: 16198009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional Study of
    Lorenzon L; Quilles JC; Campagnaro GD; Azevedo Orsine L; Almeida L; Veras F; Miserani Magalhães RD; Alcoforado Diniz J; Rodrigues Ferreira T; Kaysel Cruz A
    ACS Infect Dis; 2022 Mar; 8(3):516-532. PubMed ID: 35226477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.